![](https://inheritedcancer.net/wp-content/uploads/Screenshot-2024-08-09-124128.png)
![](https://inheritedcancer.net/wp-content/uploads/Screenshot-2024-08-09-124138.png)
![](https://inheritedcancer.net/wp-content/uploads/Screenshot-2024-08-09-124205.png)
![](https://inheritedcancer.net/wp-content/uploads/Screenshot-2024-08-09-124217.png)
![](https://inheritedcancer.net/wp-content/uploads/Screenshot-2024-08-09-124229.png)
![](https://inheritedcancer.net/wp-content/uploads/Screenshot-2024-08-09-124238.png)
A new study of 25,591 women found:
- 9.1% had a low genetic risk for breast cancer
- those with low genetic risk could potentially safely delay screening by 5 to 10 years without any impact on their health
Based on genetic risk, identifying individuals at:
- higher risk gives an opportunity to offer screening earlier and more often
- lower risk gives an opportunity to have screening delayed to a time when risk becomes high enough to warrant screening
This study challenges a one-size-fits all mammogram screening approach. This approach could possibly reduce rising healthcare costs by reallocating resources and lower unnecessary anxiety that comes with frequent screenings, and even prevent unnecessary procedures.
Read the full article to learn more at: https://tinyurl.com/dyjh7bh4
Reference: Bolze et al. JAMA Oncol. 2024;10(2):236-239. PMID: 38153744.